School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Mental Health Center, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
Front Neural Circuits. 2022 Nov 8;16:973561. doi: 10.3389/fncir.2022.973561. eCollection 2022.
To systematically evaluate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) on spasticity after upper motor neuron (UMN) injury. Eight electronic databases were searched from inception to August 6, 2022. Randomized controlled trials (RCTs) investigating the effectiveness and safety of rTMS on spasticity after UMN injury were retrieved. Two reviewers independently screened studies, extracted data, and assessed the risk of bias. Review Manager 5.3 and Stata 14.0 software were used to synthesize data. The certainty of the evidence was appraised with the Grade of Recommendation, Assessment, Development and Evaluation tool. Forty-two studies with a total of 2,108 patients were included. The results of meta-analysis revealed that, compared with control group, rTMS could significantly decrease scores of the Modified Ashworth Scale (MAS) in patients with UMN injury. The subgroup analysis discovered that rTMS effectively decreased the MAS scores in patients with stroke. Meanwhile, rTMS treatment > 10 sessions has better effect and rTMS could decrease the MAS scores of upper limb. Thirty-three patients complained of twitching facial muscles, headache and dizziness, etc. In summary, rTMS could be recommended as an effective and safe therapy to relieve spasticity in patients with UMN injury. However, due to high heterogeneity and limited RCTs, this conclusion should be treated with caution.
系统评价重复经颅磁刺激(rTMS)对上运动神经元(UMN)损伤后痉挛的疗效和安全性。从建库到 2022 年 8 月 6 日,检索了 8 个电子数据库。检索了评估 rTMS 对上运动神经元损伤后痉挛疗效和安全性的随机对照试验(RCT)。两位审查员独立筛选研究、提取数据并评估偏倚风险。使用 Review Manager 5.3 和 Stata 14.0 软件对数据进行综合分析。使用推荐、评估、发展和评估工具(GRADE)评估证据的确定性。纳入 42 项研究,共 2108 例患者。荟萃分析结果表明,与对照组相比,rTMS 可显著降低 UMN 损伤患者改良 Ashworth 量表(MAS)评分。亚组分析发现,rTMS 可有效降低脑卒中患者的 MAS 评分。同时,rTMS 治疗>10 次的效果更好,rTMS 可降低上肢的 MAS 评分。33 例患者诉面部肌肉抽搐、头痛、头晕等。总之,rTMS 可作为一种有效、安全的治疗方法,用于缓解 UMN 损伤患者的痉挛。但是,由于存在高度异质性和有限的 RCT,该结论应谨慎对待。